Brent Ness became the chief executive officer of Aclarion in September 2021. He is a highly accomplished executive with over 25 years of medical device and healthcare technology experience, specializing in leading innovative companies through pre-FDA clearance, high-growth commercialization, and international market expansion. Before joining Aclarion, Ness served as president and chief commercial officer of Cleerly Inc., where he was instrumental in building key industry partnerships, including with Canon Inc., to successfully drive the adoption of their AI-enabled cardiology solution. Previously, as chief operating officer of Mighty Oak Medical, he oversaw the progression of principal products, such as the FIREFLY platform, from pre-FDA clearance through to a full international market launch. He also served as chief commercial officer of HeartFlow Inc., where he and the executive team led the company through pre-FDA clearance and executed a global expansion of early adopter sites. Additionally, as president of ProNerve LLC, Ness successfully led a strategic roll-up and consolidation of the highly fragmented Interoperative nerve monitoring industry. His extensive experience also includes senior leadership roles at industry giants Medtronic, GE Healthcare, and Philips North America. Mr. Ness holds a BS in Business Administration from the University of North Dakota and an MBA from the University of Colorado.